# US 2026/0305670 A1 · Method of addressing alzheimer's disease or non-alzheimer's dementia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0305670 A1
- Document ID: US20260305670A1
- Status: Published application
- Kind: A1
- Application number: 19/707,752
- Filed: 2026-06-15
- Published: 2026-10-08
- Earliest claimed: 2022-04-28
- Assignees: G. Nofar Food Agency Ltd.
- Applicants: G. Nofar Food Agency Ltd.
- Inventors: Gil NOFAR
- Web page: https://patentgrep.com/patent/US20260305670A1

## CPC

- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 9/1682: {Processes}
- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 36/5777: {Theobroma, e.g. cocao or cocoa}
- A61K 36/742: {Coffea, e.g. coffee}
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method for treating, attenuating the progression, or delaying the onset of clinical symptoms, of Alzheimer's disease or non-Alzheimer's includes administering a therapeutically effective amount of a composition comprising tahina and probiotic bacteria to a subject. The composition is formulated for oral administration; and the tahina has been microfluidized by passing through a fixed-geometry homogenization channel at a pressure of at least 5000 PSI.

## Claims

### Claim 1

A method for treating, attenuating the progression, preventing, or delaying the onset of clinical symptoms, of Alzheimer's disease or non-Alzheimer's dementia, in a subject in need thereof, said method comprising administering to said subject a therapeutically effective amount of a composition comprising tahina and probiotic bacteria,
wherein said composition is formulated for oral administration; and said tahina has been microfluidized by passing through a fixed-geometry homogenization channel at a pressure of at least 5000 PSI.

### Claim 2 (depends on 1)

The method of claim 1, wherein said tahina has been microfluidized by passing through a fixed-geometry homogenization channel at a pressure of at least 20,000 PSI.

### Claim 3 (depends on 1)

The method of claim 1, wherein said composition further comprises at least one polyphenol originating in a plant other than sesame.

### Claim 4 (depends on 3)

The method of claim 3, wherein said tahina has been microfluidized together with said at least one polyphenol.

### Claim 5 (depends on 1)

The method of claim 1, wherein said tahina is hulled tahina essentially consisting of ground hulled sesame seeds, hulled tahina essentially consisting of ground hulled sesame seeds in combination with sesame hulls, unhulled tahina essentially consisting of ground unhulled sesame seeds, or unhulled tahina essentially consisting of ground unhulled sesame seeds in combination with ground hulled sesame seeds and/or sesame hulls.

### Claim 6 (depends on 5)

The method of claim 5, wherein said tahina comprises sesamin in an amount of from about 200 to about 11000 mcg/g; sesamolin in an amount of from about 100 to about 8500 mcg/g; and sesamol in an amount of from about 10 to about 5000 mcg/g.

### Claim 7 (depends on 1)

The method of claim 1, wherein said tahina exhibits a particle size distribution (PSD) wherein 99% of the particles have a size of 195 μm or less, 90% of the particles have a size of 115 μm or less, and/or 50% of the particles have a size of 9 μm or less, as measured by laser diffraction analysis in a wet dispersion using an non-aqueous, isoparaffinic hydrocarbon fluid as a dispersant.

### Claim 8 (depends on 7)

The method of claim 7, wherein said tahina exhibits a PSD wherein 99% of the particles have a size of 151 μm or less, 90% of the particles have a size of 87 μm or less, and/or 50% of the particles have a size of 7 μm or less.

### Claim 9 (depends on 8)

The method of claim 8, wherein said tahina exhibits a PSD wherein 99% of the particles have a size of 80 μm or less, 90% of the particles have a size of 45 μm or less, and/or 50% of the particles have a size of 7 μm or less.

### Claim 10 (depends on 3)

The method of claim 3, wherein said at least one polyphenol originating in a plant other than sesame comprises an extract from at least one item selected from the group consisting of seeds, beans, whole grains, nuts, fruits, and leaves, of a plant other than sesame.

### Claim 11 (depends on 10)

The method of claim 10, wherein said polyphenol comprises an extract from grapes, tea, pomegranates, dates, berries, olives, coffee beans, and/or cocoa beans.

### Claim 12 (depends on 11)

The method of claim 11, wherein said polyphenol comprises a green tea extract (GTE), grape seed extract (GSE), or a combination thereof.

### Claim 13 (depends on 12)

The method of claim 12, wherein said polyphenol comprises epigallocatechin gallate (EGCG).

### Claim 14 (depends on 1)

The method of claim 1, wherein said probiotic bacteria are selected from the group consisting of a Lactobacillus species, Bifidobacterium species, Enterococcus species, Streptococcus species, Pediococcus species, Leuconostoc species, Bacillus species, Escherichia species, and a combination thereof.

### Claim 15 (depends on 14)

The method of claim 14, wherein said Lactobacillus species is Lactobacillus acidophilus, Lactobacillus casei, or Lactobacillus plantarum; and said Bifidobacterium species is selected from the group consisting of Bifidobacterium pseudocatenulatum, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, and Bifidobacterium breve.

### Claim 16 (depends on 1)

The method of claim 1, wherein said tahina comprises sesamin in an amount of from about 200 to about 11000 mcg/g; sesamolin in an amount of from about 100 to about 8500 mcg/g; and sesamol in an amount of from about 10 to about 5000 mcg/g, and exhibits a PSD wherein 99% of the particles have a size of 151 μm or less, 90% of the particles have a size of 87 μm or less, and/or 50% of the particles have a size of 7 μm or less, as measured by laser diffraction analysis in a wet dispersion using an non-aqueous, isoparaffinic hydrocarbon fluid as a dispersant; and said probiotic bacteria are selected from the group consisting of a Lactobacillus species, Bifidobacterium species, Enterococcus species, Streptococcus species, Pediococcus species, Leuconostoc species, Bacillus species, Escherichia species, and a combination thereof.

### Claim 17 (depends on 16)

The method of claim 16, wherein said tahina exhibits a PSD wherein 99% of the particles have a size of 80 μm or less, 90% of the particles have a size of 45 μm or less, and/or 50% of the particles have a size of 7 μm or less; said Lactobacillus species is Lactobacillus acidophilus, Lactobacillus casei, or Lactobacillus plantarum; and said Bifidobacterium species is selected from the group consisting of Bifidobacterium pseudocatenulatum, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, and Bifidobacterium breve.

### Claim 18 (depends on 3)

The method of claim 3, wherein said tahina comprises sesamin in an amount of from about 200 to about 11000 mcg/g; sesamolin in an amount of from about 100 to about 8500 mcg/g; and sesamol in an amount of from about 10 to about 5000 mcg/g, and exhibits a PSD wherein 99% of the particles have a size of 151 μm or less, 90% of the particles have a size of 87 μm or less, and/or 50% of the particles have a size of 7 μm or less, as measured by laser diffraction analysis in a wet dispersion using an non-aqueous, isoparaffinic hydrocarbon fluid as a dispersant; said at least one polyphenol originating in a plant other than sesame comprises an extract from at least one item selected from the group consisting of seeds, beans, whole grains, nuts, fruits, and leaves, of a plant other than sesame; and said probiotic bacteria are selected from the group consisting of a Lactobacillus species, Bifidobacterium species, Enterococcus species, Streptococcus species, Pediococcus species, Leuconostoc species, Bacillus species, Escherichia species, and a combination thereof.

### Claim 19 (depends on 18)

The method of claim 18, wherein said tahina exhibits a PSD wherein 99% of the particles have a size of 80 μm or less, 90% of the particles have a size of 45 μm or less, and/or 50% of the particles have a size of 7 μm or less; said polyphenol comprises an extract from grapes, tea, pomegranates, dates, berries, olives, coffee beans, and/or cocoa beans; said Lactobacillus species is Lactobacillus acidophilus, Lactobacillus casei, or Lactobacillus plantarum; and said Bifidobacterium species is selected from the group consisting of Bifidobacterium pseudocatenulatum, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, and Bifidobacterium breve.

### Claim 20 (depends on 19)

The method of claim 19, wherein said extract comprises a GTE, GSE, or a combination thereof.

### Claim 21 (depends on 20)

The method of claim 20, wherein:
(i) said extract comprises EGCG; or
(ii) said GTE is an aqueous ethanol extract obtained from Camellia sinensis leaves; and/or said GSE is an aqueous extract obtained from Californian grape varieties including Ruby red grape variety; or
(iii) said composition comprises tahina, GSE, GTE, and L. plantarum powder at a weight ratio of about 30:30:16:27, respectively.

### Claim 22 (depends on 21)

The method of claim 21, wherein said GTE comprises about 95% polyphenols containing at least 70% catechins and at least 40% EGCG, and about 5% caffeine; and/or said GSE comprises epigallocatechin, catechin, epicatechin, EGCG, epicatechin gallate, total catechins, and quercetin, in an amount of about 0.21, 3.76, 4.94, 0.49, 0.13, 9.53, and 50.0 g/100 g, respectively.

### Claim 23 (depends on 1)

The method of claim 1, wherein said composition is in the form of a liquid, semi-solid, or solid; or an oral dosage form comprising a pH-dependent enteric-coating polymer capable of protecting said composition from gastric (stomach) acidity.

### Claim 24 (depends on 1)

The method of claim 1, for treating, attenuating the progression, preventing, or delaying the onset of clinical symptoms, of Alzheimer's disease.
